Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus
ICD-10 Z22.321 is a billable code used to indicate a diagnosis of carrier or suspected carrier of methicillin susceptible staphylococcus aureus.
Z22.321 is used to identify individuals who are carriers or suspected carriers of Methicillin susceptible Staphylococcus aureus (MSSA). This condition is significant as MSSA can lead to serious infections, particularly in immunocompromised individuals or those undergoing invasive procedures. The identification of carriers is crucial for infection control, especially in healthcare settings. Social determinants of health, such as living conditions, access to healthcare, and socioeconomic status, can influence the risk of MSSA colonization and subsequent infections. Preventive measures, including screening and education about hygiene practices, are essential in managing carriers to prevent transmission. Regular follow-ups and aftercare are necessary to monitor the health status of carriers and to implement strategies to reduce the risk of infection.
Documentation should include patient history, risk factors for MSSA colonization, and preventive measures taken.
Routine checkups where MSSA screening is performed, follow-up visits for carriers, and education on hygiene practices.
Consideration of social determinants such as living conditions, access to healthcare, and patient education.
Documentation should focus on population-level data, surveillance of MSSA carriers, and preventive strategies implemented.
Epidemiological studies, community health screenings, and public health interventions targeting MSSA transmission.
Emphasis on tracking health status and implementing community-wide preventive measures.
Used when screening for MSSA in a patient identified as a carrier.
Documentation of the need for screening based on carrier status.
Primary care providers should ensure comprehensive documentation of risk factors.
Z22.321 should be used when a patient is identified as a carrier or suspected carrier of MSSA, particularly in preventive care and screening contexts.
